Literature DB >> 1326310

Intraductal breast cancer: review of 183 consecutive cases.

L Cataliotti1, V Distante, S Ciatto, S Bianchi, P Pacini, R Simoncini, M Rosselli Del Turco, G Cardona, F Falli.   

Abstract

The aim was to review a series of 183 intraductal breast cancer to define the diagnostic features and therapeutic outcome. Patients' average age was 54 years. Diagnostic procedures employed were clinical examination, mammography in 173 cases and fine-needle aspiration cytology in 98 cases. The sensitivity of clinical examination was 0.61, of mammography 0.74, of fine needle aspiration cytology 0.70. The sensitivity of clinical examination and mammography associated was 0.93. The surgical options adopted were: conservative surgery 80 cases, mastectomy 103 cases. Conservative surgery was followed by breast irradiation in 34 cases. Axillary dissection was performed in 122. 97 cases have been reviewed histologically. 60% of ductal carcinoma in situ (DCIS) were multifocal and 22% multicentric. Local recurrence, all infiltrating, occurred in the same breast after conservative surgery in 8 cases, 3 of which had received postoperative radiotherapy, and in 3 patients after mastectomy. Contralateral breast cancer was recorded in 13 cases, being synchronous in 4 (infiltrating in 3, DCIS in 1) and metachronous in 8 (all infiltrating). 3 patients died of breast cancer. The present series confirms the risk of ipsilateral cancer recurrence after conservative surgery but there are no significant differences relating to mammographic pattern, size, histological type, margin involvement and radiotherapy.

Entities:  

Mesh:

Year:  1992        PMID: 1326310     DOI: 10.1016/0959-8049(92)90150-z

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  7 in total

Review 1.  Network meta-analysis of margin threshold for women with ductal carcinoma in situ.

Authors:  Shi-Yi Wang; Haitao Chu; Tatyana Shamliyan; Hawre Jalal; Karen M Kuntz; Robert L Kane; Beth A Virnig
Journal:  J Natl Cancer Inst       Date:  2012-03-22       Impact factor: 13.506

Review 2.  Association between patient and tumor characteristics with clinical outcomes in women with ductal carcinoma in situ.

Authors:  Tatyana Shamliyan; Shi-Yi Wang; Beth A Virnig; Todd M Tuttle; Robert L Kane
Journal:  J Natl Cancer Inst Monogr       Date:  2010

Review 3.  The Association of Surgical Margins and Local Recurrence in Women with Ductal Carcinoma In Situ Treated with Breast-Conserving Therapy: A Meta-Analysis.

Authors:  M Luke Marinovich; Lamiae Azizi; Petra Macaskill; Les Irwig; Monica Morrow; Lawrence J Solin; Nehmat Houssami
Journal:  Ann Surg Oncol       Date:  2016-08-15       Impact factor: 5.344

Review 4.  Current management of ductal carcinoma in situ.

Authors:  A Barth; R J Brenner; A E Giuliano
Journal:  West J Med       Date:  1995-10

5.  Is there a role for postmastectomy radiation therapy in ductal carcinoma in situ?

Authors:  Manjeet Chadha; Jason Portenoy; Susan K Boolbol; Alyssa Gillego; Louis B Harrison
Journal:  Int J Surg Oncol       Date:  2012-06-13

6.  Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.

Authors:  N Bijker; J L Peterse; I S Fentiman; J-P Julien; A A M Hart; A Avril; L Cataliotti; E J T Rutgers
Journal:  Br J Cancer       Date:  2002-09-09       Impact factor: 7.640

7.  Evaluating the efficacy of post-surgery adjuvant therapies used for ductal carcinoma in situ patients: a network meta-analysis.

Authors:  Li Wang; Yaoxiong Xia; Dequan Liu; Yueqin Zeng; Li Chang; Lan Li; Yu Hou; Lv Ge; Wenhui Li; Zhijie Liu
Journal:  Oncotarget       Date:  2017-04-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.